Diabetes mellitus as a risk factor for SARS-CoV-2 test positivity in Mexico: A propensity score matched study.
Journal
Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
18
04
2021
revised:
13
06
2021
accepted:
09
07
2021
pubmed:
24
7
2021
medline:
30
10
2021
entrez:
23
7
2021
Statut:
ppublish
Résumé
We sought to investigate whether individuals with diabetes have a higher likelihood of testing positive for SARS-CoV-2, as a proxy for infection risk, than individuals without diabetes. We conducted a cross-sectional study of publicly available data among a Mexican population, totaling 2,314,022 adults ≥ 18 years who underwent SARS-CoV-2 testing between March 1 and December 20, 2020. We used 1:1 nearest neighborhood propensity score matching by diabetes status to account for confounding among those with and without diabetes. In the overall study population, 1,057,779 (45.7%) individuals tested positive for SARS-CoV-2 and 270,486 (11.7%) self-reported diabetes. After propensity score matching, patient characteristics were well-balanced, with 150,487 patients in the diabetes group (mean [SD] age 55.9 [12.7] years; 51.3% women) and 150,487 patients in the no diabetes group (55.5 [13.3] years; 50.3% women). The strictest matching algorithm (1:1 nearest neighbor) showed that compared to individuals without diabetes, having diabetes was associated with 9.0% higher odds of having a positive SARS-CoV-2 test (OR 1.09 [95% CI: 1.08-1.10]). Presence of diabetes was associated with higher odds of testing positive for SARS-CoV-2, which could have important implications for risk mitigation efforts for people with diabetes at risk of SARS-CoV-2 infection.
Identifiants
pubmed: 34298043
pii: S0168-8227(21)00313-2
doi: 10.1016/j.diabres.2021.108953
pmc: PMC8331361
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108953Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR002542
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007028
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest DJW reports serving on a data monitoring committee for Novo Nordisk. JBM reports serving as an Academic Associate for Quest Diagnostics. All other authors declare no competing interests.
Références
Diabetes. 1990 Mar;39(3):271-5
pubmed: 2407580
JAMA. 2003 Jun 4;289(21):2801-9
pubmed: 12734147
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
Stat Med. 1998 Oct 15;17(19):2265-81
pubmed: 9802183
BMJ. 2020 Dec 11;371:m4809
pubmed: 33310819
Clin Res Cardiol. 2020 May;109(5):531-538
pubmed: 32161990
Diabetes Care. 2021 Feb;44(2):526-532
pubmed: 33268335
Bull World Health Organ. 2021 Mar 01;99(3):209-219B
pubmed: 33716343
Menopause. 2014 Aug;21(8):861-8
pubmed: 24496083
Immunol Lett. 2000 Nov 1;74(3):239-44
pubmed: 11064109
Diabetes Care. 2020 Oct;43(10):e127-e128
pubmed: 32796010
Int J Equity Health. 2020 Jul 29;19(1):126
pubmed: 32727486
Diabetes Care. 2020 Dec;43(12):2938-2944
pubmed: 32847827
Clin Infect Dis. 2005 Aug 1;41(3):281-8
pubmed: 16007521
Diabetes Care. 2018 Mar;41(3):513-521
pubmed: 29330152
PLoS One. 2021 Aug 31;16(8):e0256447
pubmed: 34464393
Curr Med Res Opin. 2016 Jul;32(7):1243-52
pubmed: 26986190
Lancet Infect Dis. 2013 Sep;13(9):752-61
pubmed: 23891402
Diabetes Care. 2021 Feb;44(2):373-380
pubmed: 33208487
BMC Infect Dis. 2018 Feb 5;18(1):67
pubmed: 29402218
PLoS One. 2020 Apr 16;15(4):e0230752
pubmed: 32298264
J Clin Endocrinol Metab. 2020 Aug 1;105(8):
pubmed: 32474598
MMWR Morb Mortal Wkly Rep. 2012 Oct 12;61(40):820
pubmed: 23051613
Diabet Med. 1997 Jan;14(1):29-34
pubmed: 9017350
Salud Publica Mex. 2020 Jan-Feb;62(1):50-59
pubmed: 31869561